KIMBERLY NELSON: Open Payments
NPI 1831478221 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 4 payments from 3 companies in 2025. Trend: 2023 $4,714 · 2024 $4,587 · 2025 $654
Speaker / faculty: $500Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $500 |
| Kite Pharma, Inc. | 1 | $97 |
| E.R. Squibb & Sons, L.L.C. | 1 | $57 |
Products named: CALQUENCE, Yescarta, REBLOZYL.
Industry payments across CA — which companies pay providers there.
